Q2 Earnings Estimate for LENZ Issued By HC Wainwright
LENZ Therapeutics, Inc. (NASDAQ:LENZ – Free Report) – Equities researchers at HC Wainwright issued their Q2 2025 EPS estimates for LENZ Therapeutics in a report released on Thursday, March 20th. HC Wainwright analyst M. Caufield anticipates that the company will post earnings of ($0.60) per share for the quarter. The consensus estimate for LENZ Therapeutics’ […]
